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Background: The main aim of this study, using a spatial-temporal model, is to analyse the link between a
deprivation index and the incidence of prostate and cervical cancer in the Girona Health Region (GHR).
Methods: This is a population-based study which includes all the inhabitants in the GHR in the period 1993–2006.
In order to assess prostate/cervical cancer risk, Besag, York and Mollie (BYM)’s spatial-temporal version of the model
was used and four random effects were introduced: (non-spatial) unstructured variability, spatial dependency,
temporal dependency and spatial-temporal interaction. As an explanatory variable, a deprivation index was
introduced at the census tract level. Furthermore, the percentage of the population between 45–64 years of age
and over-65 was also considered as explanatory variables.
Results: In the case of prostate cancer, all the variables which were introduced into the model showed a significant
correlation with the relative risk, except for the second quintile of the deprivation index. Furthermore, as the index
increased the correlation became negative and lower. Thus, the correlation between the relative risk and the two
age bands proved to be lower, the higher the age was. In the case of cervical cancer, only the correlation between
the over-65 age band and the relative risk was found to be statistically significant and positive.
Conclusions: In the case of prostate cancer, the results obtained in the GHR are in line with similar analyses.
However, in the case of cervical cancer, no significant relationship between incidences in this location or economic
status was found.
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standardization problemBackground
The study of incidence and mortality in small areas and
their relationship with different socioeconomic indica-
tors has recently been attracting a growing interest in
different countries [1-6]. Not only can individual fac-
tors explain the causes of the disease, but so too must
the contextual factors of the area of residence be taken
into account, particularly in small areas, as those* Correspondence: gemma.renart@udg.edu
1Research Group on Statistics, Applied Economics and Health (GRECS), CIBER
of Epidemiology and Public Health (CIBERESP), University of Girona, Campus
de Montilivi, Girona 17071, Spain
Full list of author information is available at the end of the article
© 2014 Vicens et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.characteristics may contribute to the socioeconomic
and environmental differences in health.
In the case of cancer, there are various studies which
show how the contextual factors of place (i.e. area of
residence) can have an effect not only the incidence of
cancer, but also on mortality rates. It would appear that
the most disadvantaged areas tend to have higher mor-
tality rates [1,3,5-8].
This study focuses on this relationship for the par-
ticular cases of prostate cancer and cervical cancer.
According to Ferlay et al., 2013 [9] when both sexes
are combined prostate cancer is the fourth most com-
mon cancer and the second most frequently occurringLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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commonly occurring cancer in women and the seventh
most frequent overall.
Prostate cancer is the second most common cancer in
European men and represents approximately 12.1% of
all newly diagnosed cancer cases [9]. In Europe, inci-
dence rates vary greatly. The highest rates were esti-
mated in northern and western European countries
(such as Norway and France) and the lowest in the cen-
tral and eastern European countries (e.g. Republic of
Moldova and Albania) [9].
In Spain prostate cancer, ahead of lung cancer, is the
most common tumour found in men. Approximately
20,000 cases per year are diagnosed, which represents
21% of all tumours among men [9]. The estimated in-
cidence rate for the Spanish population in 2012 is 96.8
cases per 100.000 males [9] and so is similar to other
developed countries. In the case of the GHR, the inci-
dence rate is estimated to be 97.6 cases per 100 000
males per year [10,11].
In the majority of cases, a diagnosis of prostate cancer
occurs between 60 and 80 years of age, although there
are a significant number of cases from 50 years of age
onwards, with the average age being 69. In general,
prostate cancer may be considered to be a tumour
which is more typical in older men [12].
Since the introduction of the Prostate Specific Antigen
screening in Spain, the rate of diagnosis has increased
significantly but the specific mortality rate has in fact de-
creased [13-17].
Cervical cancer is the fourth most common neopla-
sia among women in the world today and represents a
seventh of all neoplasias [9]. As in the case of prostate
cancer, there are significant differences between more
and less developed countries: while in the latter case it
is, after breast cancer, the second most commonly oc-
curring tumour, in developed countries its frequency
has decreased significantly in recent decades thanks to
prevention and early detection strategies and cam-
paigns [18]. 83% of the cases of cervical cancer diag-
nosed each year occur in developing countries [19],
and are, ahead of breast cancer, the most frequent
cause of death from cancer in those countries. The es-
timated incidence for the Spanish population is 7.69
per 100 000 women [18].
The average age at diagnosis is 48 years old, although
approximately 47% of women with cervical cancer are
diagnosed before the age of 35, and only 10% are diag-
nosed in women over the age of 65 [10].
In Spain, approximately 2 100 cases are diagnosed an-
nually; representing 3.3% of cancers in women and with
7.6 new cases/100 000 women/year the incidence of
cervical cancer may be considered one of the lowest in
the world [20].The main aim of this study, using the spatial-
temporal version of the Besag, York and Mollie model
[21,22], is to analyse the variation in incidence of both
neoplasias according to the area of residence and in re-
lationship to socioeconomic deprivation in the Girona
Health Region (GHR).Methods
Data setting
The present study was undertaken within the frame-
work of the MEDEA project and one of the objectives
was to estimate the relative risks associated with a
deprivation index for various cancer locations in
the Girona Health Region (GHR), (which basically
coincides with the Province of Girona, in the north
of Catalonia, Spain), and to ascertain whether this
deprivation index could explain part of the spatial vari-
ability found in some of these locations [6,23].
All the residents in the GHR (which according to the
2006 municipal population register were 670 096 inhabi-
tants of whom 339 839 were males and 330 257 females)
were considered as a study population. The study took
place from 1993 to 2006, both inclusive, and the geo-
graphical area of analysis was the census tract.
In this paper, the analysis was performed on data pro-
vided by the Girona Cancer Registry [24,25] for incident
cases of prostate cancer (ICD-10: C61) in men, and cer-
vical cancer (ICD-10: C53) in women.
To capture the specific socioeconomic contextual ef-
fects of geographic location on health, a deprivation
index (DI) at the census tract level was introduced into
the model as an explanatory variable. The DI was con-
structed by aggregating sixteen socio-economic vari-
ables, available in the Spanish Census of Population
and Housing, 2001, using the DP2 method, an iterative
procedure that weights partial indicators depending on
their correlation with the global index. Details may be
found in Salcedo et al. [26].Statistical analysis
In order to explain the variation of incidence in cases of
both prostate and cervical cancer, a full Bayesian per-
spective was followed and a spatial-temporal version of
the Besag, York and Mollie model [21,22] (BYM) was
used. In particular, a probability distribution (prior dis-
tribution) was assigned to the parameters and in order
to gather together all the unexplained variability, four
random effects were introduced into the model: i) (non-
spatial) unstructured variability, ii) spatial dependency,
iii) temporal dependency and iv) spatial-temporal inter-
action. It should be noted that separability between
spatial and temporal patterns was assumed and inter-
action between the two components was allowed.
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βjQ:indexjit þ log Pobitð Þ þ γ1P4564it
þγ2P65Mit þ υi þ Si
þτt þ ηit
ð1Þ
where the subscript i denoted the census tract (i = 1,
…,542); t the year (1993,…,2006); μ
it was the mean of
the observed cases, E(Oit); Oit was the number of cases
observed in each census tract i and year t; Pobit denoted
the population of the census tract i and year t; Q.indexj
denoted a dummy variable relative to the quintile j of
the deprivation index, for each census tract i and year t
(the first quintile was taken as a reference category).
P4564it was the percentage of the population between 45
and 64 (both inclusive); and P65Mit the percentage of
the population over 65 (both in the census tract i and
year t). The group aged under 44 did not appear in the
model in order to avoid problems of co-linearity with
the rest. Finally, βs and γs denoted unknown parameters.
Here, the parameters of interest were βj, or better, exp
(βj), the relative risks associated to the quintiles of the
deprivation index.
It should be noted that in the specified model the
number of cases expected in the census tract were not
used as an offset, but rather the population (men or
women) of the same. This is because unlike the standard
BYM model, here, the crude incidence rate (from the
census tract) was used as an indicator of mortality and
not the standardised incidence ratio. The reason for this
was to avoid the so-called ‘mutual standardisation’ prob-
lem [26,27]. Rosenbaun and Rubin [28] show how the use
of standardised rates as the response variable in ecological
regression models leads to biased results if only the answer,
and not the predictor, is adjusted for the same confounder,
usually age distribution. When the predictor is not ad-
justed, it is implicitly assumed that its effect is constant for
all strata of the confounding variable. Grisotto et al. [29],
in line with Rosenbaun and Rubin [28], show that unbiased
estimators can be obtained by adjusting the response and
predictors (the index of deprivation in this case) with the
same variable (age distribution) or, even more straightfor-
wardly, by using crude rates as the response variable and
entering age (as an average or structured) as an explana-
tory variable of the model. This is why the age structure of
the census tract (proportion of men and women aged 45
to 64 and 65 years or over) was introduced. The introduc-
tion of age also enabled its effect in the model to be con-
trolled [26].
With random effects: υι denoted heterogeneity and
captures the spatially unstructured variation of relative
risks. It was made up of zero-mean independent Gaussian
random variables on i (census tract), with a constant vari-
ance,. Si was the random effect which captures the spatialvariability and to do this a parametric model was estab-
lished. Specifically, and following the recent work of Lindg-






Γ νð Þ2ν−1 κhð Þ
νK ν κhð Þ
where h denoted the Euclidean spatial distance between
the centroids of census tracts i and j; σ2S was the variance
of the spatial structured term; Kν denoted the modified
Bessel function of the second kind and order ν >0, with ν
as the smoothing parameter. In this paper ν in 1 was fixed.
κ (κ >0) was a scaling parameter related to the range, in
other words, the distance at which the spatial correlation
becomes almost nil.
Both the temporal dependence, τt (on t, i.e. the year)
and the spatial-temporal interaction, ηit (on j and t) were
assumed smoothed functions for Gaussian vectors of
random variables, in particular random walks of order 1
and RW1 were constructed assuming independent incre-
ments [32]:
Δxi ¼ xiþ1∼N 0; 1ð Þ
The density for x is derived from its n-1 increments
as:









where Q = τR and R is the structure matrix reflecting
the neighbourhood structure of the model.
Typically, in a standard BYM, a Poisson model is as-
sumed for approximating the distribution of the count
observation. In this case, however, the data generating
process resulted in a larger number of zero counts than
would be expected (in the case of prostate cancer there
were 54.5% observed zero counts vs. the expected 35.1%;
assuming the same mean). If this were the case, the dis-
persion of the Poisson model would underestimate the
observed dispersion. Thus in the case of prostate cancer,
a mixed-distribution model was also used, specifically a
zero-inflated Poisson (ZIP) [33,34]. In the case of cer-
vical cancer, there were 94.4% zero counts observed,
5.4% of the census tracts with one count and only 0.2%
of the census tracts with two counts. For this reason, it
was considered that for cervical cancer we had a dichot-
omous response, (zero counts vs. at least one count)
leading to a binomial distribution.
For Bayesian computation, that is to say for obtaining
the marginal posterior distributions for each of the ele-
ments of the parameters vector, the INLA approach
[35] was used. In short, a Gaussian Markov random
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from a stochastic partial differential equation (SPDE)
whose solution is a Gaussian field (GF) with a Matérn co-
variance function [30]. Rather than using a regular lattice,
as is standard practice and which would imply an estimate
with a high computational cost and very little efficiency
[30], a Matérn spatial covariance structure in a triangula-
tion (triangulation of Delaunay [36]) of the GHR was spe-
cified, i.e. with very low computational cost and, most
importantly in this context, much greater efficiency.
All analyses were conducted using the free software
environment R (version 2.14.2) [37] and INLA [32,35]
(integrated nested Laplace approximation).
A natural way to compare models is to use the criter-
ion based on a trade-off between the fit of the data to
the model and the corresponding complexity of the
model. Deviance Information Criterion (DIC) is the
Bayesian model comparison criterion based on this
principle) [38]:
DIC ¼ ‘goodness of fit’þ ‘complexity’ ¼ D θ þ 2pD
where D θ
 
is the deviance evaluated at the posterior
mean of the parameters and pD denotes the ‘effective
number of parameters’ which measures the complexity
of the model [38]. DIC may under penalise complex
models with many random effects [39,40]. For this rea-
son the conditional predictive ordinate (CPO) [41,42]
was also used. CPO expresses the posterior probability
of observing the value (or set of values) of y when the
model is fitted to all data except yi, CPOt = π(yt
obs|y− t)
(y− t denotes the observations y with the i-th component
omitted). This facilitates the computation of the cross-
validated log-score, cv.ls, (cv.ls = −(mean(log(cpo)))) [43],
for model choice. Both the lower DIC and the lower cv.
ls involve the best model.
Results
The results obtained in the estimations of the models
outlined above are shown in Tables 1 and 2 in the case
of prostate cancer, and in Table 3 for cervical cancer. In
each case, Estimation 1 corresponds to the model (1)
without the spatial-temporal interaction and Estimation
2 corresponds to the model with interaction. As has
been previously mentioned, in the case of prostate can-
cer, different estimations have been carried out depend-
ing on whether the Poisson model or the zero-inflated
Poisson model was used (Tables 1 and 2, respectively).
In general it can be noted how the fit in both calcula-
tions for all cases (DIC and CPO) is practically identical,
although it is slightly better in Calculation 1. In addition,
in the case of prostate cancer (Table 1) and in the case
of cervical cancer (Table 3), it can be observed how both
the deviation of the random effect, which captures thespatial variability, and the standard deviation of the ran-
dom effect, which captures the unstructured variability,
behave in a similar way. However, in the case of prostate
cancer (Table 2) it has a different pattern. The deviation
of the random effect, which captures the unstructured
variability, is slightly lower for Estimation 2.
It can also be observed that for prostate cancer the
significant relative risk statistic associated with the quin-
tiles of the deprivation index and the age ranges intro-
duced into the model do not vary between the two
estimations in each model (Tables 1 and 2); however,
there are differences between both models.
In the first case (Table 1), all the explanatory variables
were significant except for the second quintile of the
deprivation index. It should be noted that the associ-
ation of the relative risk with this variable is negative
and decreases as the deprivation index increases. The as-
sociation of the relative risk with the age ranges included
in the model is also statistically significant; namely being
lower at higher ages. In the second case (Table 2), con-
siderable differences are evident in this respect, with the
only statistically significant association being the associ-
ation of relative risk with the fourth and fifth quintiles of
the deprivation index. However, this relationship main-
tains the same trend observed in the previous case: the
higher the deprivation index, the lower the relative risk.
In the case of cervical cancer (Table 3), in terms of the
statistical significance of the explanatory variables with
the relative risk, the results obtained for both estima-
tions are identical; that is, only the correlation between
the over-65 age range and the relative risk is significant
and positive.
Discussion and conclusions
The results of this paper show that the higher the
deprivation, the lower the risk of incidence of prostate
cancer. However, in the case of cervical cancer the geo-
graphical variability of its incidence is not explained by
deprivation.
With the statistical results, while the fit is slightly bet-
ter in the models without spatial-temporal interaction,
the estimated relative risks are practically the same in
the models with or without interaction. In fact, in all
cases, spatial dependency dominates, with a typical devi-
ation practically twice that of temporal dependency. This
may mean that the spatial incidence pattern for both
types of cancer has remained stable during the period
under consideration.
In reference to the incidence of prostate cancer, while
very few, there are other studies which have also found
that relative risks associated with deprivation are lower
than unity [44-47]. This could be related with the stage
and grade of the cancer at diagnosis, which is more ad-
vanced in areas with higher levels of deprivation. In fact,
Table 1 Results of the Bayesian computation- prostate cancer
Prostate cancer (men)
ESTIMATE 1* ESTIMATE 2*
Mean (95% credibility interval) Mean (95% credibility interval)
RRdeprivation
RRQ2-deprivation 0.8592 (0.7008, 1.0051) 0.8625 (0.7036, 1.0055)
RRQ3-deprivation 0.8129 (0.6618, 0.9980) 0.8136 (0.6624, 0.9991)
RRQ4-deprivation 0.7315 (0.6025, 0.8878) 0.7308 (0.6016, 0.8872)
RRQ5-deprivation 0.5768 (0.4771, 0.6969) 0.5766 (0.4769, 0.6968)
Log RR Population
Pop. 45–64 years old 3.8208 (1.0350, 6.6063) 3-9326 (1.1603, 6.7041)
Pop. 65 years old or older 2.4520 (0.4642, 4.4275) 2.4266 (0.4522, 4.3879)
Random effects standard error
Temporal dependency 0.03028 0.02958
Heterogeneity 0.02954 0.03083
Spatial dependency 0.09561 0.09623
Spatial-temporal interaction - 0.00201
DIC 10724.91 10729.93
-log (mean (cpo)) 1.0689 1.0695
Shaded, the 95% credibility interval did not contain the unit (i.e. statistically significant at 95%).
*Estimation 1: Model with separability between spatial and temporal patterns and without interaction between these.
Estimation 2: Model with separability between spatial and temporal patterns and with interaction between these.
Table 2 Results of the Bayesian computation- prostate cancer
Prostate cancer (men)
ESTIMATE 1* ESTIMATE 2*
Mean (95% credibility interval) Mean (95% credibility interval)
RRdeprivation
RRQ2-deprivation 0.8152 (0.6298, 1.0527) 0.8198 (0.6326, 1.0598)
RRQ3-deprivation 0.8030 (0.6190, 1.0393) 0.8063 (0.6208, 1.0446)
RRQ4-deprivation 0.7441 (0.5845, 0.9473) 0.7454 (0.5848, 0.9499)
RRQ5-deprivation 0.6000 (0.4712, 0.7622) 0.5998 (0.4706, 0.7627)
Log RR Population
Pop. 45–64 years old 2.7372 (−1.3453, 6.8193) 2.9080 (−1.1261, 6.9473)
Pop. 65 years old or older 2.5813 (−0.6199, 5.7470) 2.4672 (−0.6904, 5.5819)
Random effects standard error
Temporal dependency 0.04279 0.00675
Heterogeneity 0.04576 0.04519
Spatial dependency 0.03810 0.04213
Spatial-temporal interaction - 0.00204
DIC 11289.16 11293.09
-log(mean(cpo)) 1.1239 1.1244
Shaded, the 95% credibility interval did not contain the unit (i.e. statistically significant at 95%).
*Estimation 1: Model with separability between spatial and temporal patterns and without interaction between these.
Estimation 2: Model with separability between spatial and temporal patterns and with interaction between these.
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Table 3 Results of the Bayesian computation- cervical cancer
Cervical cancer (women)
ESTIMATE 1* ESTIMATE 2*
Mean (95% credibility interval) Mean (95% credibility interval)
RRdeprivation
RRQ2-deprivation 0.4114 (0.0251, 6.7160) 0.4067 (0.0247, 6.6799)
RRQ3-deprivation 0.9395 (0.1042, 12.9488) 0.9485 (0.1049, 13.1051)
RRQ4-deprivation 0.8123 (0.1136, 9.6775) 0.8143 (0.1136, 9.7240)
RRQ5-deprivation 1.1477 (0.1680, 13.1919) 1.1360 (0.1659, 13.0802)
Log RR Population
Pop. 45–64 years old 22.9553 (−15.4972, 63.1097) 22.6265 (−15.8452, 62.9551)
Pop. 65 years old or older 22.1030 (6.8930, 34.5706) 22.3107 (6.9830, 34.9207)
Random effects standard error
Temporal dependency 0.00628 0.00636
Heterogeneity 0.00637 0.00650
Spatial dependency 0.05099 0.05210
Spatial-temporal interaction - 0.00447
DIC 2288.77 2289.19
-log(mean(cpo)) 0.2223 0.2224
Shaded, the 95% credibility interval did not contain the unit (i.e. statistically significant at 95%).
*Estimation 1: Model with separability between spatial and temporal patterns and without interaction between these.
Estimation 2: Model with separability between spatial and temporal patterns and with interaction between these.
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portunistic screening for prostate cancer via prostate spe-
cific antigen (PSA) by those from a lower socioeconomic
level [11,48]. However, no differences in PSA levels [48]
nor in mortality for prostate cancer were found [8,48].
In contrast, cervical cancer (statistically significant) af-
fects more women from lower socioeconomic levels
[49,50]. In our case, while we have not been able to find
a statistically significant relationship, we did find a sig-
nificantly higher relative risk than unity for very high
levels of deprivation. Some causes of this could be re-
lated to increased sexual activity among women in areas
with high levels of deprivation and/or to the immigra-
tion of women coming from countries which have a high
prevalence of the viral infection human papillomavirus.
As an ecological design was used, this can be consid-
ered the main limitation of this work and therefore the
usual caveats must be taken into account. In this sense,
while the methods applied in ecological regressions may
describe the spatial-temporal distribution of incidence,
they do not explain why the risk is higher in some small
areas. For this, further studies with individual data which
evaluate the risk factors of specific causes of incidence
are needed [21]. In fact, it is well known that in eco-
logical studies a relationship between exposure and the
factor risk studied cannot be obtained since it is not
known whether individuals more exposed to a certain
factor in each geographic area are in the case study. In
our case however, we did not have any individual-levelsocioeconomic indicator to verify this fact. This represents
a significant limitation since, at least for the incidence
of prostate cancer, independent effects of socioeco-
nomic status at the individual level, and deprivation, in
terms of geographical area (ecological level) have been
found [44,45,47].
In short, we found that deprivation may in fact limit
access to health services, resulting in a late diagnosis
and therefore an increase in the incidence of prostate
cancer. Thus, putting screening and prevention pro-
grams into place could reasonably contribute to redu-
cing health inequalities; at the very least in the case of
prostate cancer incidence.
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